Articles by Diana K. Lloyd - Pharmaceutical Executive


Articles by Diana K. Lloyd

Legal: Shifting Perspective on Off-Label Promotion

A recent court case points to the government's shifting perspective on how it prosecutes companies for promoting off-label. Instead of criminal charges, hefty corporate integrity agreements might be in store.
Jan 1, 2006

The omission of criminal charges for off-label promotion of Serostim is surprising, because the government's earlier plea with Pfizer sent a strong signal that it would criminally charge companies engaged in off-label marketing.


Click here